ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

Harkin, Bumpers Concerned Over Centers Funding

May 5, 1989

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

Mass. Passes Tobacco Tax, ACS Lauds Victory Over Cigarette Industry

November 20, 1992

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010